Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH. van Straalen KR, et al. Among authors: vilarrasa e. J Am Acad Dermatol. 2021 Aug;85(2):369-378. doi: 10.1016/j.jaad.2020.12.089. Epub 2021 Jan 20. J Am Acad Dermatol. 2021. PMID: 33484766 Free article.
Serum Zinc Levels in Hidradenitis Suppurativa: A Case-Control Study.
Poveda I, Vilarrasa E, Martorell A, García-Martínez FJ, Segura JM, Hispán P, Sánchez-Payá J, Álvarez PJ, González I, Pascual JC. Poveda I, et al. Among authors: vilarrasa e. Am J Clin Dermatol. 2018 Oct;19(5):771-777. doi: 10.1007/s40257-018-0374-5. Am J Clin Dermatol. 2018. PMID: 30043129
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.
Deza G, Notario J, Lopez-Ferrer A, Vilarrasa E, Ferran M, Del Alcazar E, Carrascosa JM, Corral M, Salleras M, Ribera M, Puig L, Pujol RM, Vidal D, Gallardo F. Deza G, et al. Among authors: vilarrasa e. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):553-559. doi: 10.1111/jdv.15288. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30317679
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
Schneller-Pavelescu L, Vergara-de Caso E, Martorell A, Romaní J, Lázaro M, Vilarrasa E, Díaz-Ley B, Vázquez-Osorio I, Segura Palacios JM, Azaña JM, González-López MA, Cañueto J, Molina-Leyva A, Leiva-Salinas M, Navarro-Triviño FJ, Sánchez-Payá J, Pascual JC. Schneller-Pavelescu L, et al. Among authors: vilarrasa e. J Am Acad Dermatol. 2019 May;80(5):1455-1457. doi: 10.1016/j.jaad.2018.12.043. Epub 2019 Jan 8. J Am Acad Dermatol. 2019. PMID: 30630028 No abstract available.
Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".
Schneller-Pavelescu L, Vergara-de Caso E, Martorell A, Romaní J, Lázaro M, Vilarrasa E, Díaz-Ley B, Vázquez-Osorio I, Segura Palacios JM, Azaña JM, González-López MA, Cañueto J, Molina-Leyva A, Leiva-Salinas M, Navarro-Triviño FJ, Sánchez-Payá J, Pascual JC. Schneller-Pavelescu L, et al. Among authors: vilarrasa e. J Am Acad Dermatol. 2023 May;88(5):e271-e272. doi: 10.1016/j.jaad.2019.03.006. Epub 2019 Mar 11. J Am Acad Dermatol. 2023. PMID: 30872153 No abstract available.
76 results